Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
NextFoods is a functional food and biotechnology company focused on the development and commercialization of probiotic products under the GoodBelly brand. Based in Boulder, Colorado, the company was founded by industry veterans Steve Demos and Todd Beckman to bring scientifically-backed digestive health solutions to the mainstream market. Their core technology involves the use of the Lactobacillus plantarum 299v strain, which is one of the most well-researched probiotic strains for gut health and immune support. NextFoods offers a variety of delivery formats, including juice drinks, concentrated shots, and shelf-stable supplements. In 2023, the company was acquired by The Hain Celestial Group, integrating its probiotic expertise into a global health and wellness platform.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on NextFoods International.